Onco-003

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOnco-003
Drug Alias Nameanticancer mAb program (arGEN-X)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArgenx Se
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArgenx Se
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A